| Product NDC: | 11026-2640 |
| Proprietary Name: | Broncotron |
| Non Proprietary Name: | Dextromethorphan, Guaifenesin |
| Active Ingredient(s): | 10; 100 mg/5mL; mg/5mL & nbsp; Dextromethorphan, Guaifenesin |
| Administration Route(s): | ORAL |
| Dosage Form(s): | LIQUID |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 11026-2640 |
| Labeler Name: | Seyer Pharmatec, Inc. |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part341 |
| Marketing Category: | OTC MONOGRAPH FINAL |
| Start Marketing Date: | 19980101 |
| Package NDC: | 11026-2640-4 |
| Package Description: | 118 mL in 1 BOTTLE (11026-2640-4) |
| NDC Code | 11026-2640-4 |
| Proprietary Name | Broncotron |
| Package Description | 118 mL in 1 BOTTLE (11026-2640-4) |
| Product NDC | 11026-2640 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Dextromethorphan, Guaifenesin |
| Dosage Form Name | LIQUID |
| Route Name | ORAL |
| Start Marketing Date | 19980101 |
| Marketing Category Name | OTC MONOGRAPH FINAL |
| Labeler Name | Seyer Pharmatec, Inc. |
| Substance Name | DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN |
| Strength Number | 10; 100 |
| Strength Unit | mg/5mL; mg/5mL |
| Pharmaceutical Classes |